These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 26074961)
1. Treatment of Primary Aldosteronism and Organ Protection. Catena C; Colussi G; Sechi LA Int J Endocrinol; 2015; 2015():597247. PubMed ID: 26074961 [TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases]. Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213 [TBL] [Abstract][Full Text] [Related]
3. Management of primary aldosteronism: its complications and their outcomes after treatment. Giacchetti G; Turchi F; Boscaro M; Ronconi V Curr Vasc Pharmacol; 2009 Apr; 7(2):244-49. PubMed ID: 19356005 [TBL] [Abstract][Full Text] [Related]
4. Primary aldosteronism: renaissance of a syndrome. Young WF Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946 [TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism. Catena C; Colussi G; Di Fabio A; Valeri M; Marzano L; Uzzau A; Sechi LA Horm Metab Res; 2010 Jun; 42(6):440-5. PubMed ID: 20119883 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment. Sechi LA; Colussi G; Di Fabio A; Catena C Am J Hypertens; 2010 Dec; 23(12):1253-60. PubMed ID: 20706195 [TBL] [Abstract][Full Text] [Related]
7. Approach to the surgical management of primary aldosteronism. Iacobone M; Citton M; Viel G; Rossi GP; Nitti D Gland Surg; 2015 Feb; 4(1):69-81. PubMed ID: 25713782 [TBL] [Abstract][Full Text] [Related]
8. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859 [TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era. Catena C; Colussi G; Sechi LA Eur J Endocrinol; 2013 Jan; 168(1):C1-5. PubMed ID: 23082005 [TBL] [Abstract][Full Text] [Related]
10. Primary aldosteronism: A common and curable form of hypertension. Young WF Cardiol Rev; 1999; 7(4):207-14. PubMed ID: 10423672 [TBL] [Abstract][Full Text] [Related]